MedPath

Feasibility study of percutaneus endoscopic gastrostomy with Direct IDEAL PEG for patients with active head and neck cancer and esophageal cancer.

Not Applicable
Conditions
patients with active head and neck cancer and esophageal cancer
Registration Number
JPRN-UMIN000000542
Lead Sponsor
ational Cancer Center Hospital East
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. impossible of passage of endoscopy 2. exsisting of fistula 3. after gastrectomy 4. active infection 5. risk of GI bleeding 6. massive ascites 7. disapproval of withdraw of anti coaguration agent 8. addiction of steroids 9. severe heart disease and uncontrolled hypertention and diabete 10. terminal stage within 4 months prognosis 11. ineligible judged by doctor in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
completion rate of PEG
Secondary Outcome Measures
NameTimeMethod
Incidence of adverse event Incidence of severe adverse event
© Copyright 2025. All Rights Reserved by MedPath